Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development-Reference-Cited by-同舟云学术

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

Published:2022-08 Issue: Volume:Volume 9 Page:823-837
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Haque Abedul,Sahu Vishal,Lombardo Jamie Lynne,Xiao Lianchun,George Bhawana,Wolff Robert A,Morris Jeffrey S,Rashid Asif,Kopchick John J,Kaseb Ahmed O,Amin Hesham M^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference68 articles.

1. International trends in hepatocellular carcinoma incidence, 1978–2012

2. Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pesticides impacts on human health and the environment with their mechanisms of action and possible countermeasures;Heliyon;2024-04

2. Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-03

3. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors;Cell Communication and Signaling;2024-01-25

4. A cluster of X-linked miRNAs are de-repressed with age in mouse liver and target growth hormone signaling;Frontiers in Aging;2023-10-10

5. Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma;Frontiers in Molecular Biosciences;2023-10-03